Zdrowie i gospodarka · 02/06/2025
FDA Clears Epinephrine Solution for Intravenous Use
The FDA has determined that a specific epinephrine solution, 1mg/mL, prefilled syringe for intravenous use, was not withdrawn from sale due to safety or effectiveness concerns, allowing it to continue being approved through abbreviated new drug applications.
Source: Federal Register — Food and Drug AdministrationOpen original release →